This study demonstrates squaramide compound HR-19011 inhibits hematologic malignancies and activates the HRI–eIF2α–ATF4 pathway.
IC50 values of squaramide-based compounds in K562 cells with normal and reduced HRI expression levels
No takes yet. Share an insight, caveat, or question.
Kim et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: